Go Pro
→ Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid (From Altimetry) (Ad)tc pixel Free IVF Stock Alerts

INVO Fertility (IVF) Competitors

INVO Fertility logo
$1.04 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.02 -0.02 (-1.44%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

IVF vs. HSCS, MBAI, NDRA, NVNO, and SINT

Should you buy INVO Fertility stock or one of its competitors? MarketBeat compares INVO Fertility with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with INVO Fertility include HeartSciences (HSCS), Check-Cap (MBAI), ENDRA Life Sciences (NDRA), enVVeno Medical (NVNO), and Sintx Technologies (SINT). These companies are all part of the "medical equipment" industry.

How does INVO Fertility compare to HeartSciences?

INVO Fertility (NASDAQ:IVF) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, risk, valuation and profitability.

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 17.2% of HeartSciences shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by company insiders. Comparatively, 4.9% of HeartSciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

INVO Fertility currently has a consensus target price of $20.00, suggesting a potential upside of 1,823.08%. HeartSciences has a consensus target price of $8.00, suggesting a potential upside of 211.28%. Given INVO Fertility's stronger consensus rating and higher probable upside, equities analysts plainly believe INVO Fertility is more favorable than HeartSciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
HeartSciences
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

HeartSciences has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. HeartSciences' return on equity of -333.50% beat INVO Fertility's return on equity.

Company Net Margins Return on Equity Return on Assets
INVO Fertility-183.75% -420.62% -45.21%
HeartSciences N/A -333.50%-140.18%

INVO Fertility has a beta of 2.28, suggesting that its share price is 128% more volatile than the broader market. Comparatively, HeartSciences has a beta of 1.78, suggesting that its share price is 78% more volatile than the broader market.

In the previous week, HeartSciences had 2 more articles in the media than INVO Fertility. MarketBeat recorded 2 mentions for HeartSciences and 0 mentions for INVO Fertility. HeartSciences' average media sentiment score of 0.49 beat INVO Fertility's score of 0.00 indicating that HeartSciences is being referred to more favorably in the news media.

Company Overall Sentiment
INVO Fertility Neutral
HeartSciences Neutral

HeartSciences has lower revenue, but higher earnings than INVO Fertility. HeartSciences is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INVO Fertility$6.84M0.27-$25.13M-$352.18N/A
HeartSciencesN/AN/A-$8.77M-$4.94N/A

Summary

HeartSciences beats INVO Fertility on 9 of the 16 factors compared between the two stocks.

How does INVO Fertility compare to Check-Cap?

Check-Cap (NASDAQ:MBAI) and INVO Fertility (NASDAQ:IVF) are both small-cap medical equipment companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability.

Check-Cap has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. Check-Cap's return on equity of 0.00% beat INVO Fertility's return on equity.

Company Net Margins Return on Equity Return on Assets
Check-CapN/A N/A N/A
INVO Fertility -183.75%-420.62%-45.21%

Check-Cap has a beta of 0.65, indicating that its stock price is 35% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.28, indicating that its stock price is 128% more volatile than the broader market.

In the previous week, Check-Cap had 3 more articles in the media than INVO Fertility. MarketBeat recorded 3 mentions for Check-Cap and 0 mentions for INVO Fertility. Check-Cap's average media sentiment score of 0.00 equaled INVO Fertility'saverage media sentiment score.

Company Overall Sentiment
Check-Cap Neutral
INVO Fertility Neutral

1.1% of Check-Cap shares are held by institutional investors. Comparatively, 12.0% of INVO Fertility shares are held by institutional investors. 0.5% of Check-Cap shares are held by insiders. Comparatively, 0.4% of INVO Fertility shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Check-Cap has higher earnings, but lower revenue than INVO Fertility. Check-Cap is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Check-CapN/AN/A$4.14M-$2.01N/A
INVO Fertility$6.84M0.27-$25.13M-$352.18N/A

INVO Fertility has a consensus target price of $20.00, suggesting a potential upside of 1,823.08%. Given INVO Fertility's stronger consensus rating and higher possible upside, analysts plainly believe INVO Fertility is more favorable than Check-Cap.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Check-Cap
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

Summary

Check-Cap and INVO Fertility tied by winning 7 of the 14 factors compared between the two stocks.

How does INVO Fertility compare to ENDRA Life Sciences?

ENDRA Life Sciences (NASDAQ:NDRA) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, media sentiment, institutional ownership and valuation.

ENDRA Life Sciences has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. INVO Fertility's return on equity of -420.62% beat ENDRA Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
ENDRA Life SciencesN/A -433.64% -204.58%
INVO Fertility -183.75%-420.62%-45.21%

ENDRA Life Sciences has a beta of -0.06, meaning that its share price is 106% less volatile than the broader market. Comparatively, INVO Fertility has a beta of 2.28, meaning that its share price is 128% more volatile than the broader market.

ENDRA Life Sciences presently has a consensus price target of $25.00, indicating a potential upside of 405.05%. INVO Fertility has a consensus price target of $20.00, indicating a potential upside of 1,823.08%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than ENDRA Life Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ENDRA Life Sciences
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, ENDRA Life Sciences' average media sentiment score of 0.00 equaled INVO Fertility'saverage media sentiment score.

Company Overall Sentiment
ENDRA Life Sciences Neutral
INVO Fertility Neutral

1.2% of ENDRA Life Sciences shares are owned by institutional investors. Comparatively, 12.0% of INVO Fertility shares are owned by institutional investors. 10.0% of ENDRA Life Sciences shares are owned by insiders. Comparatively, 0.4% of INVO Fertility shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

ENDRA Life Sciences has higher earnings, but lower revenue than INVO Fertility. ENDRA Life Sciences is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ENDRA Life SciencesN/AN/A-$7.03M-$8.15N/A
INVO Fertility$6.84M0.27-$25.13M-$352.18N/A

Summary

INVO Fertility beats ENDRA Life Sciences on 9 of the 14 factors compared between the two stocks.

How does INVO Fertility compare to enVVeno Medical?

INVO Fertility (NASDAQ:IVF) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations.

In the previous week, enVVeno Medical had 2 more articles in the media than INVO Fertility. MarketBeat recorded 2 mentions for enVVeno Medical and 0 mentions for INVO Fertility. enVVeno Medical's average media sentiment score of 0.30 beat INVO Fertility's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company Overall Sentiment
INVO Fertility Neutral
enVVeno Medical Neutral

INVO Fertility has a beta of 2.28, indicating that its stock price is 128% more volatile than the broader market. Comparatively, enVVeno Medical has a beta of 1.09, indicating that its stock price is 9% more volatile than the broader market.

enVVeno Medical has lower revenue, but higher earnings than INVO Fertility. enVVeno Medical is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INVO Fertility$6.84M0.27-$25.13M-$352.18N/A
enVVeno MedicalN/AN/A-$19.47M-$25.54N/A

12.0% of INVO Fertility shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 0.4% of INVO Fertility shares are held by insiders. Comparatively, 15.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

INVO Fertility currently has a consensus price target of $20.00, suggesting a potential upside of 1,823.08%. Given INVO Fertility's stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
enVVeno Medical
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.33

enVVeno Medical has a net margin of 0.00% compared to INVO Fertility's net margin of -183.75%. enVVeno Medical's return on equity of -66.39% beat INVO Fertility's return on equity.

Company Net Margins Return on Equity Return on Assets
INVO Fertility-183.75% -420.62% -45.21%
enVVeno Medical N/A -66.39%-60.42%

Summary

enVVeno Medical beats INVO Fertility on 8 of the 14 factors compared between the two stocks.

How does INVO Fertility compare to Sintx Technologies?

INVO Fertility (NASDAQ:IVF) and Sintx Technologies (NASDAQ:SINT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

INVO Fertility has a net margin of -183.75% compared to Sintx Technologies' net margin of -1,058.60%. Sintx Technologies' return on equity of -366.49% beat INVO Fertility's return on equity.

Company Net Margins Return on Equity Return on Assets
INVO Fertility-183.75% -420.62% -45.21%
Sintx Technologies -1,058.60%-366.49%-115.04%

12.0% of INVO Fertility shares are owned by institutional investors. Comparatively, 18.4% of Sintx Technologies shares are owned by institutional investors. 0.4% of INVO Fertility shares are owned by company insiders. Comparatively, 4.1% of Sintx Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

INVO Fertility currently has a consensus target price of $20.00, indicating a potential upside of 1,823.08%. Sintx Technologies has a consensus target price of $9.33, indicating a potential upside of 494.48%. Given INVO Fertility's higher possible upside, research analysts plainly believe INVO Fertility is more favorable than Sintx Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INVO Fertility
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
2.50
Sintx Technologies
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

Sintx Technologies has lower revenue, but higher earnings than INVO Fertility. Sintx Technologies is trading at a lower price-to-earnings ratio than INVO Fertility, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INVO Fertility$6.84M0.27-$25.13M-$352.18N/A
Sintx Technologies$1.02M6.65-$10.36M-$5.07N/A

In the previous week, INVO Fertility's average media sentiment score of 0.00 equaled Sintx Technologies'average media sentiment score.

Company Overall Sentiment
INVO Fertility Neutral
Sintx Technologies Neutral

INVO Fertility has a beta of 2.28, meaning that its share price is 128% more volatile than the broader market. Comparatively, Sintx Technologies has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

Summary

INVO Fertility and Sintx Technologies tied by winning 7 of the 14 factors compared between the two stocks.

Get INVO Fertility News Delivered to You Automatically

Sign up to receive the latest news and ratings for IVF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IVF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IVF vs. The Competition

Export
MetricINVO FertilitySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.86M$44.91M$6.90B$12.28B
Dividend YieldN/A1.08%2.67%9.39%
P/E Ratio0.0018.2227.1023.94
Price / Sales0.2728.91517.5191.92
Price / CashN/A18.8626.6847.25
Price / Book0.309.2010.666.14
Net Income-$25.13M-$16.99M$3.60B$331.74M
7 Day Performance-7.96%-3.30%-1.51%-1.72%
1 Month Performance-30.67%-3.33%1.11%-1.44%
1 Year Performance-98.97%-14.46%23.77%16.97%

INVO Fertility Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IVF
INVO Fertility
1.7393 of 5 stars		$1.04
flat		$20.00
+1,823.1%		-99.0%$1.86M$6.84MN/A10
HSCS
HeartSciences
2.1181 of 5 stars		$2.60
-0.9%		$8.00
+208.0%		-31.4%$8.17MN/AN/A10
MBAI
Check-Cap
0.264 of 5 stars		$1.02
-9.7%		N/AN/A$7.44MN/AN/A80
NDRA
ENDRA Life Sciences
1.8402 of 5 stars		$5.56
+0.3%		$25.00
+350.0%		-29.9%$7.06MN/AN/A20
NVNO
enVVeno Medical
1.9375 of 5 stars		$10.48
-3.9%		N/A-93.8%$7.02MN/AN/A30

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:IVF) was last updated on 7/20/2026 by MarketBeat.com Staff.
From Our Partners
Backed Company Could Save Power Grid
A small Colorado company holds the rights to technology that could protect the U.S. public power grid from col...
Altimetry | Sponsoredtc pixel
BlackRock is hoarding it. JPMorgan is hoarding it. Do you own it?
BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...
Awesomely | Sponsoredtc pixel
Buy this stock tomorrow
Marc Chaikin, founder of Chaikin Analytics, is flagging a little-known company that just secured a partnership...
Chaikin Analytics | Sponsoredtc pixel
I found Rolls-Royce at $2 - now I see the same setup again
In 2022, Karim Rahemtulla recommended Rolls-Royce under $2 - a misunderstood aerospace name the market had wri...
Monument Traders Alliance | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
NVIDIA offered $40B. The answer was no.
Apple, NVIDIA, Google, Amazon, and Samsung all pay one company billions in royalties every year. NVIDIA tried ...
Behind the Markets | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Trump is positioned. Elon lights the fuse.
Earlier this year, the Trump-backed World Liberty Trust applied for a federal banking charter. Now, new report...
Crypto 101 Media | Sponsoredtc pixel